Drugs / Human Amnion Allograft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02344329 | Aug 2014 → Nov 2017 | diabetes mellitus, ulcer of lower limbs | University of North Dakota | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Amnion Allograft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02344329 ↗ |
| Known as | AmnioExCel | “AmnioExCel” NCT02344329 ↗ |
| Modality | Other / unclassified | “AmnioExCel® is a dehydrated, extracellular human amnion derived tissue allograft” NCT02344329 ↗ |